Title : Neo-adjuvant (before surgery) pembrolizumab
link : Neo-adjuvant (before surgery) pembrolizumab
Neo-adjuvant (before surgery) pembrolizumab
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastomahttp://sci-hub.tw/https://www.nature.com/articles/s41591-018-0337-7
The survival advantage of neoadjuvant pembrolizumab was statistically significant (hazard ratio = 0.39, P = 0.04). Note that it's more difficult to achieve statistical significance in a smaller trial versus a larger one. Patients in each arm were well-matched for typical prognostic features.
In light of the positive results of this trial, "we intend to expand the current study and pursue further clinical trials with neoadjuvant combination immunotherapeutics."
Thus Article Neo-adjuvant (before surgery) pembrolizumab
That's an article Neo-adjuvant (before surgery) pembrolizumab This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article Neo-adjuvant (before surgery) pembrolizumab with the link address https://polennews.blogspot.com/2019/02/neo-adjuvant-before-surgery.html
0 Response to "Neo-adjuvant (before surgery) pembrolizumab"
Post a Comment